Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (221-230 of 477) with videos related to

Pageof 48
Sort By:
Lupus|June 24, 2022
Predictive model of risk and severity of enteritis in systemic lupus erythematosusWeijin Zhang, Guohai Huang, Jianqun Lin, et al.
Annals of the Rheumatic Diseases|June 27, 2025
Vasculopathy, embolism, xerostomia, arthritis, and stomachacheWeijin Zhang, Songhao Cai, Shaoyu Zheng, et al.
Arthritis Research & Therapy|January 18, 2019
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Dinesh Khanna, Philip J Clements, Elizabeth R Volkmann, et al.
Seminars in Arthritis and Rheumatism|May 1, 2018
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensusFrancesca Ingegnoli, Tommaso Schioppo, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Validation of Sonography findings of synovitis and tenosynovitis of hands and wrists in patients with systemic sclerosisAnat Scheiman-Elazary, Veena K Ranganath, Ami Ben-Artzi, et al.
Rheumatology (Oxford, England)|July 2, 2013
Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritisVeena K Ranganath, Paul Maranian, David A Elashoff, et al.
Annals of the Rheumatic Diseases|November 9, 2012
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patientsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
Arthritis Care & Research|May 26, 2017
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled TrialsRajaie Namas, Donald P Tashkin, Daniel E Furst, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2021
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled TrialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Rheumatology|January 30, 2010
Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trialsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
Pageof 48

Showing results (221-230 of 477) with videos related to

Sort By:
Pageof 48
Lupus|June 24, 2022
Predictive model of risk and severity of enteritis in systemic lupus erythematosusWeijin Zhang, Guohai Huang, Jianqun Lin, et al.
Annals of the Rheumatic Diseases|June 27, 2025
Vasculopathy, embolism, xerostomia, arthritis, and stomachacheWeijin Zhang, Songhao Cai, Shaoyu Zheng, et al.
Arthritis Research & Therapy|January 18, 2019
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Dinesh Khanna, Philip J Clements, Elizabeth R Volkmann, et al.
Seminars in Arthritis and Rheumatism|May 1, 2018
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensusFrancesca Ingegnoli, Tommaso Schioppo, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Validation of Sonography findings of synovitis and tenosynovitis of hands and wrists in patients with systemic sclerosisAnat Scheiman-Elazary, Veena K Ranganath, Ami Ben-Artzi, et al.
Rheumatology (Oxford, England)|July 2, 2013
Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritisVeena K Ranganath, Paul Maranian, David A Elashoff, et al.
Annals of the Rheumatic Diseases|November 9, 2012
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patientsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
Arthritis Care & Research|May 26, 2017
Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled TrialsRajaie Namas, Donald P Tashkin, Daniel E Furst, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2021
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled TrialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Journal of Rheumatology|January 30, 2010
Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trialsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
Pageof 48